GE HealthCare Technologies (FRA:L0T) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L0T GE HealthCare Technologies Inc FRA:L0T
78 GF Score
Price €55.26
GF Value €72.23
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is GE HealthCare Technologies Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

FRA:L0T
78GF Score
GE HealthCare Technologies Inc FRA:L0T
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is GE HealthCare Technologies (FRA:L0T) Overvalued in 2026?

Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued. The current stock price of €55.26 is trading 23.5% below its estimated GF Value™ of €72.23. GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.

Key valuation signals for FRA:L0T:

  • Total Premiums Earned:
  • GF Value™: €72.23 vs. price of €55.26 (23.5% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:L0T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


GE HealthCare Technologies Business Description

Address 500 West Monroe Street, Chicago, IL, USA, 60661
GE HealthCare Technologies Inc. is a medical technology company that develops, manufactures, and services imaging, ultrasound, and patient care equipment, as well as pharmaceutical diagnostics. Its segments include imaging, advanced visualization solutions, patient care solutions, and pharmaceutical diagnostics. Products include CT, MRI, X-ray, ultrasound, and mammography systems, patient monitoring and anesthesia devices, and contrast agents used in medical imaging. Customers are primarily hospitals, health systems, clinics, and imaging centers worldwide. The company operates across the United States, Europe, the Middle East and Africa, China, and other international markets. Revenue comes from equipment sales, service contracts and maintenance, pharmaceutical diagnostics, and digital and software solutions, with a substantial portion recurring through servicing and diagnostics.
78GF Score

Get the complete analysis for FRA:L0T

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.26
Price
€72.23
GF Value